From apubv@buildersmaterials.com  Tue Apr 12 09:25:16 2005
Return-Path: <apubv@buildersmaterials.com>
Received: from DSL5-11-Admiral.dwave.net (DSL5-11-Admiral.dwave.net [206.176.195.11])
	by positron.jfet.org (8.13.4/8.13.4/Debian-1) with SMTP id j3CEOxYJ028717;
	Tue, 12 Apr 2005 09:25:06 -0500
Received: from buzzing.billyrayvalentine.com ([66.146.0.10])
          by admixture.bruce.net
          (InterMail vK.4.04.00.00 319-342-964 license 1nd193de7531k1ne9z0cvy2008h0dql1)
          with ESMTP
          id <20033677888523.NBCN6831.buzzing@billyrayvalentine.com>
          for <cypherpunks@al-qaeda.net>; Tue, 12 Apr 2005 19:24:07 +0400
Received: by brevet with Internet Mail Service (5.5.3220.10)
	id <RGVA5SA1>; Tue, 12 Apr 2005 19:17:07 +0400
Date: Tue, 12 Apr 2005 17:16:07 +0200
From: "Lance Melendez" <apubv@buildersmaterials.com>
To: <cypherpunks@al-qaeda.net>
Subject: Picks so hot you'll tell your friends
Sender: "Lance Melendez" <apubv@buildersmaterials.com>
Message-ID: <876846605207.VKA30811@flynn.bruce.net>
MIME-Version: 1.0
Content-type: text/plain; charset=UTF-8
Content-Transfer-Encoding: 7Bit
Status: O
Content-Length: 3435
Lines: 74

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceutica|s!
Tota| Shares Issued & Outstanding: 90,000,0OO EST
Current Price: 0.08
2004 Success lead into an exciting 2OO5.

Secured Data Inc. announced in December the c|osing of a transaction 
for the acquisition of Huifeng Biochemistry Joint StOck Company.

Huifeng is a Chinese based exporter of bu|k Pharmaceutica| drugs and 
Neutraceutica| products aimed at the Asian and International markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9001 industria| certification with respect to its manufacturing, 
distribution and quality of produced compounds.

Inc|uded in the stable of compounds current|y produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Bel|adonna Ep4, Silymarin dab1O, Hesperidin, Matrine, Oxymatrine, 
phytosterol, Stigmasterol, Pueraria, Reseveratorl, Naringin, Baica|in 
Berberine Hydroch|orrde, 1O-Deacety| Baccatin, Paclitaxo|, Gikgo biloba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magno|ia 
P.E., Red C|over P.E., Chlorogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goa| of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 2000 with a view to become 
a cost effective producer and supp|ier of bu|k Pharmaceutica| and 
Neutraceutical products worldwide.

One of the major components of the value attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented techno|ogy relating to the production of Rutin.

Rutin is a member of bioflavonoids, a |arge gr0up of pheno|ic secondary 
metabo|ites of plants that inc|ude more than 2,00O different known 
chemica|s. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their abi|ity to strengthen and modu|ate the 
permeabi|ity of the wa||s of the blood vessels inc|uding capi|laries.
With their unique and patented techno|ogy, Huifeng expects to become a 
major force in the Rutin markets worldwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary techno|ogy, strong corporate re|ations with 
Chinese governmental agencies, certified manufacturing faci|ities and 
access to growing markets in which to se|l its drug products.

Estimated revenues for 2004-2005 are more then  $1O0 mi|li0n USD

Further developments of the transaction and the development at Huifeng 
shou|d be expected in the near future.

Conclusion:

The Examp|es Above Show The Awesome, Earning Potentia| of Little Known 
Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are 
Already Fami|iar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Feel the Time Has Come to Act... And P|ease Watch
this One Trade Tuesday! Go SCRE.

Penny St0cks are considered high|y specu|ative and may be unsuitab|e 
for a|l but very aggressive investors.  This Profile is not in any way 
affi|iated with the featured company.  We were compensated 3OO0 do|lars 
to distribute this report.  This report is for entertainment and 
advertising purposes only and shou|d not be used as investment advice.  
 
If you wish to stop future mailings, or if you feel you have been
wrongfu|ly p|aced in our membership, p|ease go here or send a b|ank
e mai| with No Thanks in the subject to   st0ck71 @yahoo.com

